biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > ?

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Aug 13, 2021 3:02pm

190 Views

Post# 33701920

RE:RE:?

Doh, you bad, fatboy.

For me, the reporting of patent approvals at this late stage is more housekeeping than anything. They're incredibly important and confirming, but not earth (share price) moving. it would be bigger news if a patent was not issued. ("Dog bites man" is not news. "Man bites dog" is news.)

jd

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec